IP Library Granted Patent US 7,906,331
Granted Patent B2
US 7,906,331 · App. 12/574,443 · Granted Mar 15, 2011

Methods for identifying stem cells expressing breast cancer resistance protein (BCRP)

Assignee: St. Jude Children's Research Hospital
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,906,331
App. No.
12/574,443
Granted
Mar 15, 2011
Kind
B2
Abstract

The present invention includes methods of identifying and/or isolating stem cells based on expression of BCRP. The present invention also describes methods of obtaining and/or using cell populations enriched for stem cells. In addition, methods are provided for diagnosing and/or prognosing leukemia, particularly human acute myelogenous leukemia (AML), through assaying for BCRP expression in leukemic cells.

Claims (13)

1. A method of identifying BCRP-expressing stem cell comprising: (a) obtaining a cell sample which contains a stem cell; and (b) detecting the expression of BCRP by a cell in the cell sample;

wherein a cell that expresses BCRP is identified as BCRP-expressing stem cell.

2. The method of claim 1 wherein said detecting is performed with an antibody that binds to BCRP; and wherein BCRP-expressing stem cell is identified if it binds to said antibody.

3. The method of claim 1 wherein said detecting is performed with a PCR probe for the nucleic acid that expresses BCRP.

4. The method of claim 1 further comprising: (c) detecting the expression of another cell marker associated with stem cells.

5. The method of claim 4 wherein said cell marker is selected from the group consisting of CD34, Thy-1, P-gp, and c-kit.

6. The method of claim 4 wherein said cell marker is CD34 and wherein the cell is also CD38.

7. The method of claim 1 further comprising: (c) detecting the expression of a lineage specific marker.

8. The method of claim 7 wherein said BCRP-expressing stem cell is a hematopoietic stem cell.

9. A method of isolating a cell that expresses BCRP comprising: (a) obtaining a cell sample which contains a cell that expresses BCRP; (b) detecting the expression of BCRP by a cell in the cell sample; and (c) isolating the cell that expresses BCRP.

10. A method of isolating a cell that expresses BCRP comprising: (a) obtaining a cell sample which contains a cell that expresses BCRP; (b) contacting the cell sample with an antibody that binds to BCRP; and (c) isolating a cell from the cell sample that binds to said antibody; wherein the isolated cell is a cell that expresses BCRP.

11. The method of claim 10 , wherein said isolating is performed by flow cytometry.

12. The method of claim 11 , wherein said antibody has a fluorescent label and said isolating is performed by fluorescence-activated cell sorting.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 30, 2020
From: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC
To: NIH-DEITR
Reel/Frame 053094/0518 →
Continuity (5)
Continuation 09866866 · May 29, 2001
Continuation In Part 09584586 · May 31, 2000
Continuation In Part PCTUS9911825 · May 27, 1999
Provisional Application 60086988 · May 28, 1998
Related Publication 20100099105A1 · Apr 22, 2010